Select status:
Sort by:
Filter by last updated date

Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and July 2019

Filter by type
Showing 1 to 10 of 435
Title Reference number Published Last updated
Lenalidomide plus dexamethasone for multiple myeloma after 1 treatment with bortezomib Reference number:TA586 TA00586 Published:June 2019 20190601 Last updated:June 2019 20190626
Lenalidomide plus dexamethasone for previously untreated multiple myeloma Reference number:TA587 TA00587 Published:June 2019 20190601 Last updated:June 2019 20190626
Lenalidomide for treating myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality Reference number:TA322 TA00322 Published:September 2014 20140901 Last updated:June 2019 20190626
Lenalidomide for the treatment of multiple myeloma in people who have received at least 2 prior therapies Reference number:TA171 TA00171 Published:June 2009 20090601 Last updated:June 2019 20190626
Ocrelizumab for treating primary progressive multiple sclerosis Reference number:TA585 TA00585 Published:June 2019 20190601 Last updated:June 2019 20190612
Ertugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetes Reference number:TA583 TA00583 Published:June 2019 20190601 Last updated:June 2019 20190605
Atezolizumab in combination for treating metastatic non-squamous non-small-cell lung cancer Reference number:TA584 TA00584 Published:June 2019 20190601 Last updated:June 2019 20190605
Cabozantinib for previously treated advanced hepatocellular carcinoma (terminated appraisal) Reference number:TA582 TA00582 Published:May 2019 20190501 Last updated:May 2019 20190524
Enzalutamide for hormone-relapsed non-metastatic prostate cancer Reference number:TA580 TA00580 Published:May 2019 20190501 Last updated:May 2019 20190515
Nivolumab with ipilimumab for untreated advanced renal cell carcinoma Reference number:TA581 TA00581 Published:May 2019 20190501 Last updated:May 2019 20190515